Priya Patel, MD
Allergy & Immunology · Greensboro, NCNPI 1467940734
Payments from drug & device makers
Across 273 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$766
- Amgen$663
- Novartis$566
- GSK$464
- Sanofi$357
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,25598%
- Education$1552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,308 |
| Regeneron Healthcare Solutions, Inc. | 26 | $766 |
| Amgen(2 entities) | 33 | $663 |
| Novartis | 23 | $566 |
| GSK | 27 | $464 |
| Sanofi | 17 | $357 |
| CSL Behring | 13 | $346 |
| AbbVie | 12 | $222 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $180 |
| Pfizer | 2 | $153 |
| Genentech USA, Inc. | 7 | $149 |
| Biocryst US Sales Co., LLC | 6 | $138 |
| Grifols USA, LLC | 4 | $104 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Mallinckrodt Enterprises LLC | 1 | $97 |
| Boehringer Ingelheim | 1 | $94 |
| Regeneron | 2 | $73 |
| Mylan Specialty L.p. | 3 | $56 |
| Philips North America LLC | 3 | $54 |
| LEO Pharma Inc. | 3 | $51 |
| Lilly USA, LLC | 3 | $49 |
| Aytu Biopharma, Inc. | 3 | $49 |
| Octapharma USA, Inc. | 2 | $46 |
| Ionis Pharmaceuticals, Inc. | 2 | $46 |
| Pharming Healthcare, Inc. | 2 | $45 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Paratek Pharmaceuticals, Inc. | 2 | $33 |
| Optinose US, Inc. | 2 | $32 |
| Kaleo, Inc. | 2 | $32 |
| Incyte Corporation | 1 | $30 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,411 in reported general payments places this provider in the 55th percentile of 140 allergy & immunology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $21,196 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,340 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $6,111 |
| Azelastine Hcl | 148 | $5,165 |
| Epinephrine | 29 | $4,807 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,771 |
| Fluticasone Propionate | 180 | $2,932 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 14 | $2,171 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 95 | $1,921 |
| Ipratropium Bromide | 48 | $1,728 |
| Ventolin HfaAlbuterol Sulfate | 15 | $878 |
| Mometasone Furoate | 11 | $835 |
| Famotidine | 43 | $780 |
| Montelukast Sodium | 72 | $650 |
| Levocetirizine Dihydrochloride | 58 | $642 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Symbicort | $1,308 | $27,30756 claims |
| Boehringer IngelheimSpiriva Respimat | $94 | $6,34012 claims |
| Hikma Pharmaceuticals USAEpinephrine | $34 | $4,80729 claims |
| GSKBreo Ellipta | $464 | $4,77112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 140 allergy & immunology providers in North Carolina.
Other allergy & immunology in Greensboro
- Shaylar PadgettGreensboro$23K
- Craig LaforceRaleigh$7.9M
- Karen DunnRaleigh$3.3M
- Maeve OconnorCharlotte$2.2M
- David CypcarAsheville$1.6M
- Edwin KimChapel Hill$874K
- Joel HartmanWinston Salem$749K
- William McCannAsheville$710K
- Cristine RadojicicDurham$558K
- Scott ComminsChapel Hill$555K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.